| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 301 | 886 | 2.557 | 2.584 | 2.516 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 301 | 886 | 2.557 | 2.584 | 2.516 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 424 | 719 | 2.439 | 3.983 | 4.979 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | -123 | 167 | 117 | -1.399 | -2.462 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | -132 | 140 | 41 | -1.399 | -2.462 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Bio Soft Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.213 | 2.190 | 2.153 | 2.113 | 2.073 | 2.033 | 1.988 | 1.994 | 1.988 | 1.977 |
| Current Assets | 1.738 | 1.720 | 1.691 | 1.660 | 1.628 | 2.761 | 4.184 | 4.568 | 8.098 | 6.319 |
| Inventories | 1.725 | 1.707 | 1.679 | 1.648 | 1.616 | 2.671 | 4.146 | 3.844 | 6.828 | 6.145 |
| Receivables | 8 | 8 | 7 | 7 | 7 | 7 | 0 | 0 | 0 | 161 |
| Cash | 5 | 5 | 5 | 5 | 5 | 82 | 38 | 724 | 1.270 | 13 |
| Shareholders Funds | -685 | -678 | -666 | -654 | -641 | -761 | -604 | -565 | -1.963 | -4.414 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.635 | 4.588 | 4.510 | 4.427 | 4.342 | 5.555 | 6.776 | 7.127 | 12.050 | 12.711 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6201 - 6201" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Bio Soft Srl